CU20220008A7 - Forma polimórfica estable de 6-fluor0-9-metil-9h-b-carbolina - Google Patents

Forma polimórfica estable de 6-fluor0-9-metil-9h-b-carbolina

Info

Publication number
CU20220008A7
CU20220008A7 CU2022000008A CU20220008A CU20220008A7 CU 20220008 A7 CU20220008 A7 CU 20220008A7 CU 2022000008 A CU2022000008 A CU 2022000008A CU 20220008 A CU20220008 A CU 20220008A CU 20220008 A7 CU20220008 A7 CU 20220008A7
Authority
CU
Cuba
Prior art keywords
carboline
fluoro
methyl
polymorphic form
stable polymorphic
Prior art date
Application number
CU2022000008A
Other languages
English (en)
Inventor
Hans Rommelspacher
Reimar Schlingensiepen
Tomasz Zygmunt
Original Assignee
Audiocure Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Audiocure Pharma Gmbh filed Critical Audiocure Pharma Gmbh
Publication of CU20220008A7 publication Critical patent/CU20220008A7/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

<p>La presente invención se refiere a una forma polimórfica cristalina estable de 6-fluoro-9- metil-9H-β-carbolina de fórmula (I)</p> <p>Fórmula (l)</p> <p>un método para Ia preparación de dicha forma polimórfica cristalina de 6-fluoro-9-metil-9H-β-carbolina,y una composición farmacéutica que comprende dicha forma polimórfica cristalina de 6-fluoro-9-metil-9H-β-carbolina. </p>
CU2022000008A 2019-08-09 2020-08-07 Forma polimórfica estable de 6-fluor0-9-metil-9h-b-carbolina CU20220008A7 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19191150.2A EP3772515A1 (en) 2019-08-09 2019-08-09 Stable polymorphic form of 6-fluoro-9-methyl-9h-ss-carboline and uses thereof
PCT/EP2020/072328 WO2021028365A1 (en) 2019-08-09 2020-08-07 Stable polymorphic form of 6-fluoro-9-methyl-9h-b-carboline and uses thereof

Publications (1)

Publication Number Publication Date
CU20220008A7 true CU20220008A7 (es) 2022-09-08

Family

ID=67614427

Family Applications (1)

Application Number Title Priority Date Filing Date
CU2022000008A CU20220008A7 (es) 2019-08-09 2020-08-07 Forma polimórfica estable de 6-fluor0-9-metil-9h-b-carbolina

Country Status (13)

Country Link
US (1) US20220289741A1 (es)
EP (2) EP3772515A1 (es)
JP (1) JP7337254B2 (es)
CN (1) CN114269743B (es)
AU (1) AU2020329535A1 (es)
BR (1) BR112022001433A2 (es)
CA (1) CA3143605A1 (es)
CL (1) CL2022000225A1 (es)
CU (1) CU20220008A7 (es)
IL (1) IL290272A (es)
MX (1) MX2022001566A (es)
WO (1) WO2021028365A1 (es)
ZA (1) ZA202201719B (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040038970A1 (en) 1998-06-12 2004-02-26 Societe De Conseils De Recherches Etd' Application Scientifiques, S.A.S. A Paris, France Corp. Beta-carboline compounds
DE102007009264A1 (de) 2007-02-26 2008-08-28 Ellneuroxx Ltd. 9-Alkyl-ß-Carboline zur Behandlung von neurodegenerativen Erkrankungen
KR20120098855A (ko) 2009-12-28 2012-09-05 아우디오쿠레 파르마 게엠베하 청각장애 및 현기증을 치료하기 위한 β-카르볼린
EP2853533A1 (de) 2013-09-29 2015-04-01 Audiocure Pharma GmbH 6-Fluor-9-methyl-ß-carbolin

Also Published As

Publication number Publication date
CN114269743A (zh) 2022-04-01
US20220289741A1 (en) 2022-09-15
EP3772515A1 (en) 2021-02-10
CA3143605A1 (en) 2021-02-18
CN114269743B (zh) 2023-11-10
EP3972974A1 (en) 2022-03-30
CL2022000225A1 (es) 2022-09-09
ZA202201719B (en) 2023-11-29
JP2022545361A (ja) 2022-10-27
BR112022001433A2 (pt) 2022-03-22
AU2020329535A1 (en) 2022-01-20
MX2022001566A (es) 2022-03-02
JP7337254B2 (ja) 2023-09-01
WO2021028365A1 (en) 2021-02-18
IL290272A (en) 2022-04-01

Similar Documents

Publication Publication Date Title
EA201990565A1 (ru) Кристаллический 19-нор c3,3-дизамещенный c21-n-пиразолил стероид
CY1125155T1 (el) Κρυσταλλικες μορφες αναστολεα προλυλο υδροξυλασης
CO2018000589A2 (es) Oxiesteroles y composiciones farmacéuticas que los contienen
EA201890899A1 (ru) Модуляторы фарнезоидного x-рецептора
UY35300A (es) Formulación de combinación de dos compuestos antivirales
UY32490A (es) Inhibidores de beta-secretasa
CU20190086A7 (es) Compuestos de heteroarilo bicíclicos 6-6 fusionados útiles como inhibidores de lats
ECSP12011793A (es) Nuevos compuestos eficaces como inhibidores de la xantina-oxidasa, método para la preparación de los mismos y composición farmacéutica que los contiene
MX2021008002A (es) Sales nuevas y forma polimorfica del acido bempedoico.
CL2012001841A1 (es) Polimorfo cristalino de la forma a de 2-(5-bromo-4-(4-ciclopropilnaftalen-1-il)-4h-1,2,4-triazol-3-iltio)acetato de sodio; método de preparación; composición farmacéutica; y su uso para el tratamiento o prevención de hiperuricemia o una enfermedad causada por niveles elevados de ácido úrico.
CY1115043T1 (el) Φαρμακευτικο σκευασμα
MX2021002382A (es) Sales y formas cristalinas de modulador alosterico positivo gabaa.
CL2021001461A1 (es) Moduladores de trex1
CU20120137A7 (es) Hidrato del hidrocloruro de agomelatina y preparación de éste
CL2011001405A1 (es) Procedimiento para la preparacion de n-[2-(7-metoxi-1-naftil)etil]acetamida, agometalina.
EA201690072A1 (ru) Состав, содержащий гиполипидемическое средство
CL2018001210A1 (es) Compuestos de criptoficina novedosos y productos conjugados, su preparación y su uso terapéutico.
CR20160016A (es) Pirazolpiridinas sustituidas
CY1121147T1 (el) Νεες συντηγμενες ενωσεις ιμιδαζοβενζοθειαζολιου
BR112019025028A2 (pt) Método para preparar um composto.
CO2019011547A2 (es) Compuesto sólido cristalino novedoso de clorhidrato de 3-fenil-4-propil-1-(piridin-2-il)-1h-pirazol-5-ol
PH12015502154A1 (en) Composition for oral cavity
BR112014019585A8 (pt) Forma sólida de um composto, composição farmacêutica e cápsula em gel
EA201791645A1 (ru) Новые соли и полиморфы scy-078
AR109328A1 (es) Derivado de triazolopirazinona útil como un inhibidor de pde1 humana